#1 Clinical Trials Search in Europe

Esmolol Hydrochloride

Esmolol Hydrochloride, a short-acting beta-blocker, is being studied in various clinical trials for its potential benefits in treating different medical conditions. These trials aim to evaluate its effectiveness in managing heart rate, blood pressure, and other physiological parameters in situations ranging from septic shock to surgical procedures. The drug’s rapid onset and short duration of action make it an interesting candidate for precise control of cardiovascular functions in critical care settings.

Table of Contents

What is Esmolol Hydrochloride?

Esmolol Hydrochloride, also known by brand names such as Brevibloc, is a medication that belongs to a class of drugs called beta-blockers[1]. It is unique among beta-blockers because it is ultra-short-acting, meaning its effects start quickly and don’t last long in the body[2]. This characteristic makes esmolol particularly useful in certain medical situations where precise control of heart rate is needed.

How Does Esmolol Work?

Esmolol works by blocking the effects of certain stress hormones (like adrenaline) on the heart. Specifically, it targets beta-1 receptors in the heart, which are responsible for controlling heart rate and the force of heart contractions[1]. By blocking these receptors, esmolol can:

  • Slow down a rapid heart rate
  • Reduce the workload on the heart
  • Lower blood pressure

The rapid onset and short duration of esmolol’s effects allow doctors to quickly adjust the dosage based on a patient’s response, making it a valuable tool in critical care settings[2].

Medical Uses of Esmolol

Esmolol is used in various medical situations, including:

  1. Septic Shock: This is a life-threatening condition caused by a severe infection. Esmolol is being studied for its potential to improve outcomes in patients with septic shock by controlling rapid heart rate and potentially reducing inflammation[1][3].
  2. Heart Attack (Myocardial Infarction): Research is ongoing to determine if esmolol can help protect the heart during and after a heart attack by reducing heart rate and improving blood flow to the heart[4].
  3. Surgical Procedures: Esmolol is used during some surgeries to control heart rate and blood pressure, which can help reduce the risk of complications[5].
  4. Acute Respiratory Distress Syndrome (ARDS): This is a severe lung condition. Studies are investigating whether esmolol can improve oxygen levels in the blood of patients with ARDS[6].

How is Esmolol Administered?

Esmolol is typically given as an intravenous (IV) infusion in a hospital setting. The dosage and duration of treatment can vary depending on the specific medical situation and the patient’s response. Some key points about esmolol administration include:

  • It’s often started with a loading dose followed by a continuous infusion[4].
  • The dose can be adjusted frequently (every few minutes) to achieve the desired heart rate[5].
  • Treatment duration can range from a few hours to several days, depending on the medical condition being treated.

Potential Side Effects

Like all medications, esmolol can cause side effects. The most common and important ones to be aware of include:

  • Bradycardia: This means an abnormally slow heart rate[5].
  • Hypotension: This refers to low blood pressure, which can cause dizziness or fainting[5].
  • Fatigue or weakness
  • Nausea

Because esmolol is given in a hospital setting, healthcare providers closely monitor patients for these side effects and can quickly adjust the dose or stop the medication if needed.

Ongoing Research and Future Potential

Researchers are actively studying esmolol to explore its potential benefits in various medical conditions. Some areas of ongoing research include:

  • Its use in reducing pain and the need for opioid medications during and after surgery[5].
  • Potential protective effects on the brain in patients with septic shock[7].
  • Its ability to improve outcomes in patients with acute respiratory distress syndrome[6].
  • A new gel formulation of esmolol (called Galnobax) for treating diabetic foot ulcers[8].

These ongoing studies may lead to new approved uses for esmolol in the future, potentially benefiting more patients with various medical conditions.

Aspect Details
Main Uses in Trials – Managing heart rate and blood pressure in septic shock – Improving oxygenation in acute respiratory distress syndrome – Reducing opioid use in surgical procedures – Potential treatment for diabetic foot ulcers – Cardioprotective effects in myocardial infarction
Key Characteristics – Rapid onset of action (1-2 minutes) – Short duration (elimination half-life ~9 minutes) – Selective beta-1 adrenergic receptor blocker – Administered intravenously
Dosing in Trials – Varies by study and condition – Examples: – Septic shock: 20-300 μg/kg/min – Surgical procedures: 0.5 mg/kg bolus, then 50 μg/kg/min – ARDS: 10-40 μg/kg/min
Potential Benefits – Improved control of heart rate and blood pressure – Reduced inflammation and organ dysfunction in sepsis – Opioid-sparing effects in pain management – Possible improvement in wound healing (diabetic foot ulcers)
Safety Considerations – Closely monitored for bradycardia and hypotension – Short half-life allows for quick dose adjustments – Generally well-tolerated in studied populations

FAQ

  • What is Esmolol Hydrochloride? Esmolol Hydrochloride is a short-acting beta-blocker medication that works by slowing down heart rate and reducing blood pressure. It has a rapid onset of action and a very short duration, making it useful for situations where quick control of heart rate is needed.
  • In which medical conditions is Esmolol being studied? Esmolol is being studied in various conditions including septic shock, myocardial infarction (heart attack), acute respiratory distress syndrome, during surgical procedures for pain management, and in patients with diabetic foot ulcers.
  • How does Esmolol compare to other medications in clinical trials? Some trials are comparing Esmolol to other medications like dexmedetomidine or placebo. For example, one study is looking at how Esmolol and dexmedetomidine affect brain blood flow in patients with septic shock. These comparisons help researchers understand the unique benefits and potential applications of Esmolol.
  • What are the potential benefits of using Esmolol in critical care? Potential benefits being studied include improved control of heart rate and blood pressure, reduced need for other medications (like opioids for pain control), improved oxygenation in lung conditions, and possible reduction in inflammation and organ dysfunction in severe conditions like sepsis.
  • Are there any risks associated with Esmolol use in these trials? As with any medication, there are potential risks. In the case of Esmolol, the main concerns are related to its effects on heart rate and blood pressure. Trials carefully monitor for side effects such as excessive slowing of heart rate (bradycardia) or drops in blood pressure (hypotension). The short-acting nature of Esmolol allows for quick adjustments if needed.

Ongoing Clinical Trials on Esmolol Hydrochloride

  • Study on Esmolol Hydrochloride vs. Sufentanil Citrate for Recovery Quality in Patients Undergoing Laparoscopic Gallbladder Surgery with Anesthesia

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on Esmolol Hydrochloride, Dobutamine, and Milrinone for Patients with Cardiogenic Shock on V-A ECMO Support

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Esmolol for Heart Issues in Patients with Cirrhosis, Diabetes, or Cardiotoxic Treatment

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Esmolol Hydrochloride: A short-acting beta-blocker medication that slows heart rate and reduces blood pressure, with a rapid onset and short duration of action.
  • Beta-blocker: A class of medications that block the effects of adrenaline and noradrenaline on beta receptors in the body, often used to treat high blood pressure and heart conditions.
  • Septic shock: A life-threatening condition that occurs when sepsis leads to dangerously low blood pressure and abnormalities in cellular metabolism.
  • Acute Respiratory Distress Syndrome (ARDS): A serious lung condition causing fluid buildup in the air sacs (alveoli), leading to severe breathing difficulties and low blood oxygen levels.
  • Oxygenation index: A measure of how well the lungs are transferring oxygen from the air into the blood.
  • Myocardial infarction: Commonly known as a heart attack, it occurs when blood flow to part of the heart muscle is blocked, causing damage to the heart tissue.
  • Nociception: The neural process of encoding and processing harmful or potentially harmful stimuli, often associated with pain perception.
  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Pharmacodynamics (PD): The study of how a drug affects the body, including its mechanism of action and the relationship between drug concentration and effect.
  • Transcranial Doppler: A non-invasive ultrasound technique used to measure blood flow velocity in the brain's blood vessels.

References

  1. https://clinicaltrials.gov/study/NCT02068287
  2. https://clinicaltrials.gov/study/NCT01741519
  3. https://clinicaltrials.gov/study/NCT03208257
  4. https://clinicaltrials.gov/study/NCT06376630
  5. https://clinicaltrials.gov/study/NCT06291363
  6. https://clinicaltrials.gov/study/NCT06013319
  7. https://clinicaltrials.gov/study/NCT06169475
  8. https://clinicaltrials.gov/study/NCT01113515